Related references
Note: Only part of the references are listed.Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients
Aliki Ntzifa et al.
SCIENTIFIC REPORTS (2021)
Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma
Thomas J. Vogl et al.
PLOS ONE (2021)
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer
Chia-Lin Hsu et al.
LUNG CANCER (2021)
Malignancy Prediction Capacity and Possible Prediction Model of Circulating Tumor Cells for Suspicious Pulmonary Lesions
Ching-Yang Wu et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer
Xiao Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
Maxim E. Menyailo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A longitudinal, Prospective Trial
Ching-Yang Wu et al.
DIAGNOSTICS (2020)
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
Francesco Pantano et al.
SCIENTIFIC REPORTS (2020)
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial
Alessandra Gennari et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Pieter A. Boonstra et al.
CANCER AND METASTASIS REVIEWS (2020)
Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
Olga E. Savelieva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy
Fanny Le Du et al.
PLOS ONE (2020)
Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells
Saghar Yousefnia et al.
FRONTIERS IN ONCOLOGY (2020)
Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients
M. A. Elbaiomy et al.
JOURNAL OF ONCOLOGY (2020)
Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study
Almudena Zapatero et al.
RADIATION ONCOLOGY (2020)
Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance
Jiaojiao Zhou et al.
CANCER BIOLOGY & MEDICINE (2020)
Prognostic models for breast cancer: a systematic review
Minh Tung Phung et al.
BMC CANCER (2019)
The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-time Blood Drawing
Pei-Hung Chang et al.
CANCERS (2019)
CD133 in Breast Cancer Cells: More than a Stem Cell Marker
Federica Brugnoli et al.
JOURNAL OF ONCOLOGY (2019)
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
Chun-Hui Lee et al.
BMC CANCER (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
Kristine Astvatsaturyan et al.
PLOS ONE (2018)
Advances in treatment and care in metastatic breast cancer (MBC): are there MBC patients who are curable?
Masaya Hattori et al.
CHINESE CLINICAL ONCOLOGY (2018)
Patterns and predictors of first and subsequent recurrence in women with early breast cancer
Y. M. Geurts et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy
Po-Jung Su et al.
SCIENTIFIC REPORTS (2016)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients
Carolin Bock et al.
FUTURE ONCOLOGY (2014)
CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
Rosa Nadal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
Herve Sartelet et al.
HISTOPATHOLOGY (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
Po Zhao et al.
CANCER SCIENCE (2011)
Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
Hisae Iinuma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Markers of stemness in equine mesenchymal stem cells: a plea for uniformity
Catharina De Schauwer et al.
THERIOGENOLOGY (2011)
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
Panayiotis A. Theodoropoulos et al.
CANCER LETTERS (2010)
Colon Cancer Stem Cells: Promise of Targeted Therapy
Matilde Todaro et al.
GASTROENTEROLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
Massimo Cristofanilli
SEMINARS IN ONCOLOGY (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
